We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
South African Biotec Installs Roche Genome Sequencer 20
News

South African Biotec Installs Roche Genome Sequencer 20

South African Biotec Installs Roche Genome Sequencer 20
News

South African Biotec Installs Roche Genome Sequencer 20

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "South African Biotec Installs Roche Genome Sequencer 20"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Roche Diagnostics has announced that they have sold the first ultrafast Genome Sequencer 20 System (including option for the new Genome Sequencer FLX) in Africa.

South Africa’s Inqaba Biotec will be the first user in the African continent. As of March 2007, the company will offer their sequencing service to customers not only in Southern Africa but also worldwide.

The company supports all the applications available from 454 Life Sciences and Roche Diagnostics, including whole genome sequencing, Paired-End, Amplicon, etc., and provides a tailor-made service according to their customers' requirements.

Oliver Preisig, CEO of Inqaba Biotec, explains: The GS 20 sequencer from Roche is based on a cutting-edge technology for the generation and analysis of sequence data in the megabase range at a cost level that will now make it accessible to many more life scientists than ever before.

Preisig further said: We are excited that Inqaba Biotec was enabled by BioPAD, a biotechnology investment trust funded by the Department of Science and Technology of South Africa, with the aim of establishing a sequencing service based on the GS technology in South Africa to serve regional as well as international customers.

The Genome Sequencer 20 System, is based on 454 Sequencing™ technology, developed by the US Company 454 Life Sciences, and can perform sequencing runs up to 60 times faster than conventional commercially available platforms.

Advertisement